Skip Navigation Links
About UsExpand About Us
  Therapeutic Areas   Contact Us




  To enhance our areas of expertise, Lovelace Scientific Resources
is seeking to expand our investigator network.
 




 On average, there are 25,000 investigational drugs in stages
   from pre-clinical to Phase IV
 Cancer clinical studies lead the way at 25%
 Infectious diseases comprises 10.6% of drug research and development
 CNS is the third strongest research category at 10.6% out of the remaining therapeutic areas
 Of those 25,000 drugs, on average 11,000 are in pre-clinical discovery and development
 
Investigator Inquiry     
 
2441 Ridgecrest Dr. SE
Albuquerque, NM 87108
505.348.9500


If you are interested in partnering with Lovelace Scientific Resources or learning more about clinical research opportunities, click Investigator Inquiry.     




Home | Sitemap | Privacy | Contact Us   a subsidiary of Lovelace Respiratory Research Institute